Sponsor of the Day:
Jerkmate
https://www.silvec.com/
Silvec Biologics | RNA Therapies for Trees
Silvec Biologics | Protecting, curing and enhancing trees with RNA therapies
rna therapiesbiologicstrees
https://mdaquest.org/rna-therapies-offer-keys-to-treating-genetic-neuromuscular-diseases/
RNA Therapies Offer Keys to Treating Genetic Neuromuscular Diseases - Quest | Muscular Dystrophy...
Feb 24, 2026 - RNA therapies offer new hope for neuromuscular diseases, targeting faulty proteins without permanently altering DNA.
quest muscular dystrophyrna therapiesneuromuscular diseasesofferkeys
https://www.proqr.com/
ProQR Therapeutics - Creating RNA therapies for patients in need
ProQR is a biotech company that discovers and develops unique RNA therapies for severe rare and common diseases, based in Leiden, The Netherlands.
rna therapiestherapeuticscreatingpatientsneed
https://createmedicines.com/
Create Medicines | In Vivo Immune Programming with RNA-CAR Therapies
Create Medicines is pioneering in vivo immune cell programming with RNA powered, LNP delivered CAR therapies – unlocking scalable, off-the-shelf treatments for...
createmedicinesvivoimmuneprogramming
https://biox.stanford.edu/highlight/new-rna-and-protein-tools-may-improve-cell-therapies
New RNA and protein tools may improve cell therapies | Welcome to Bio-X
Two new papers from Stanford Bio-X affiliated faculty member and previous Bio-X Fellow Xiaojing Gao - one with co-lead author Stanford Bio-X Fellow Carlos A....
tools maycell therapiesbio xnewrna
https://xraised.com/videos/regenerative-medicine-reinvented-frederic-tonglet-on-conveyxos-rna-enhanced-exosome-therapies-the-future-of-treating-degenerative-disease/
Regenerative Medicine Reinvented: Frédéric Tonglet on convEyXO’s RNA-Enhanced Exosome Therapies &...
Nov 25, 2025 - In this forward-thinking Xraised interview, we sit down with Frédéric Tonglet, CEO of convEyXO, a fast-rising biotech company pioneering RNA-enhanced exosome...
regenerative medicinereinventedrnaenhancedexosome
https://www.tinostx.com/
Tinos Therapeutics | RNA-Targeted Cancer Therapies
Tinos Therapeutics develops first-in-class small molecule inhibitors targeting RNA modifications to destabilize tumor-driving RNA and treat cancer.
therapeutics rnatargeted cancertinostherapies